Northern Trust’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $14.9M | Buy |
|
|||||
|
2023
Q3 | $10.5M | Buy |
|
|||||
|
2023
Q2 | $7.76M | Buy |
|
|||||
|
2023
Q1 | $7.57M | Buy |
|
|||||
|
2022
Q4 | $8.79M | Sell |
|
|||||
|
2022
Q3 | $13.8M | Buy |
|
|||||
|
2022
Q2 | $12.9M | Sell |
|
|||||
|
2022
Q1 | $16.5M | Buy |
|
|||||
|
2021
Q4 | $29.1M | Buy |
|
|||||
|
2021
Q3 | $33.6M | Sell |
|
|||||
|
2021
Q2 | $37.6M | Sell |
|
|||||
|
2021
Q1 | $81.4M | Sell |
|
|||||
|
2020
Q4 | $109M | Buy |
|
|||||
|
2020
Q3 | $73.6M | Sell |
|
|||||
|
2020
Q2 | $52.8M | Buy |
|
|||||
|
2020
Q1 | $29.3M | Buy |
|
|||||
|
2019
Q4 | $44.7M | Sell |
|
|||||
|
2019
Q3 | $27.8M | Buy |
|
|||||
|
2019
Q2 | $30.8M | Buy |
|
|||||
|
2019
Q1 | $21.4M | Buy |
|
|||||
|
2018
Q4 | $11.6M | Buy |
|
|||||
|
2018
Q3 | $12.9M | Buy |
|
|||||
|
2018
Q2 | $12.2M | Buy |
|
|||||
|
2018
Q1 | $1.85M | Buy |
|
|||||
|
2017
Q4 | $1.01M | Buy |
|
|||||
|
2017
Q3 | $625K | Buy |
|
|||||
|
2017
Q2 | $162K | Sell |
|
|||||
|
2017
Q1 | $894K | Buy |
|
|||||
|
2016
Q4 | $673K | Sell |
|
|||||
|
2016
Q3 | $966K | Sell |
|
|||||
|
2016
Q2 | $839K | Buy |
|
|||||
|
2016
Q1 | $3.06M | Buy |
|
|||||
|
2015
Q4 | $4.36M | Buy |
|
|||||
|
2015
Q3 | $4.37M | Buy |
|
|||||
|
2015
Q2 | $2.67M | Buy |
|
|||||
|
2015
Q1 | $2.04M | Buy |
|
|||||
|
2014
Q4 | $1.17M | Sell |
|
|||||
|
2014
Q3 | $1.12M | Buy |
|